Kura Oncology, Inc. Human Resources Contracts & Agreements
34 Contracts & Agreements
- Bonus & Incentive Agreements (6 contracts)
- Compensation Agreements (4)
- Employment Agreements (21)
- Separation Agreements (3)
- Second Amendment to Amended and Restated Executive Employment Agreement, effective as of April 11, 2024, by and between the Registrant and Troy E. Wilson, Ph.D., J.D (Filed With SEC on August 8, 2024)
- Executive Employment Agreement, effective as of August 14, 2023, by and between the Registrant and Brian Powl (Filed With SEC on November 2, 2023)
- Form of International Stock Option Grant Notice, International Stock Option Agreement and International Notice of Exercise under the Kura Oncology, Inc. Amended and Restated 2014... (Filed With SEC on August 9, 2023)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 9, 2023)
- Separation Agreement, effective as of February 4, 2022, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on February 24, 2022)
- Executive Employment Agreement, effective as of October 18, 2021, by and between the Registrant and Teresa Bair (Filed With SEC on February 24, 2022)
- Form of International Restricted Stock Unit Award Grant Notice and International Restricted Stock Unit Award Agreement under the Kura Oncology, Inc. Amended and Restated 2014... (Filed With SEC on February 24, 2022)
- First Amendment to Amended and Restated Executive Employment Agreement, effective as of June 30, 2021, by and between the Registrant and Bridget Martell (Filed With SEC on August 5, 2021)
- Amendment to Executive Employment Agreement, effective as of February 22, 2021, by and between the Registrant and Stephen Dale, M.D (Filed With SEC on May 6, 2021)
- Executive Employment Agreement, effective as of July 22, 2020, by and between the Registrant and Stephen Dale, M.D (Filed With SEC on May 6, 2021)
- Amended and Restated Executive Employment Agreement, effective as of August 24, 2020, by and between the Registrant and Bridget Martell (Filed With SEC on May 6, 2021)
- Executive Employment Agreement, effective as of February 10, 2020, by and between the Registrant and Bridget Martell (Filed With SEC on May 6, 2021)
- Executive Employment Agreement, effective as of January 6, 2020, by and between the Registrant and Kirsten Flowers (Filed With SEC on May 6, 2021)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on February 24, 2021)
- Second Amendment to Executive Employment Agreement, effective as of February 19, 2021, by and between the Registrant and Troy E. Wilson, Ph.D., J.D (Filed With SEC on February 24, 2021)
- Form of International Stock Option Grant Notice, International Stock Option Agreement and International Notice of Exercise under the Kura Oncology, Inc. Amended and Restated... (Filed With SEC on November 5, 2020)
- Amended and Restated Nonemployee Director Compensation Policy (Filed With SEC on August 6, 2020)
- Separation Agreement, dated August 21, 2019, by and between the Registrant and John Farnam (Filed With SEC on May 4, 2020)
- Executive Employment Agreement, effective as of November 4, 2019, by and between the Registrant and James Basta (Filed With SEC on May 4, 2020)
- Separation Agreement, dated February 5, 2020, by and between the Registrant and Antonio Gualberto, M.D., Ph.D (Filed With SEC on February 25, 2020)
- Executive Employment Agreement, effective as of August 9, 2019, by and between the Registrant and Kathleen Ford (Filed With SEC on November 5, 2019)
- First Amendment to Executive Employment Agreement, effective as of August 21, 2018, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on November 5, 2019)
- Executive Employment Agreement, effective as of August 21, 2018, by and between the Registrant and Marc Grasso, M.D (Filed With SEC on November 5, 2018)
- Executive Employment Agreement, effective as of July 1, 2018, by and between the Registrant and John Farnam (Filed With SEC on August 6, 2018)
- Amended and Restated Executive Employment Agreement, effective as of January 29, 2016, by and between the Registrant and Heidi Henson (Filed With SEC on March 12, 2018)
- Kura Oncology, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2018)
- Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Annette North (Filed With SEC on March 17, 2016)
- Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Antonio Gualberto (Filed With SEC on March 17, 2016)
- Kura Oncology, Inc. Amended and Restated Executive Employment Agreement for Troy E. Wilson (Filed With SEC on March 17, 2016)
- First Amendment to Executive Employment Agreement (Filed With SEC on May 13, 2015)
- KURA ONCOLOGY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY (Filed With SEC on April 17, 2015)
- KURA ONCOLOGY, INC. EXECUTIVE EMPLOYMENT AGREEMENT FOR TROY WILSON (Filed With SEC on March 12, 2015)
- KURA ONCOLOGY, INC. RESTRICTED STOCK PURCHASE AWARD NOTICE (AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN) (Filed With SEC on March 12, 2015)
- KURA ONCOLOGY, INC. AMENDED AND RESTATED 2014 EQUITY INCENTIVE PLAN AMENDED AND RESTATED BY THE BOARD:MARCH 6, 2015 APPROVED BY THE STOCKHOLDERS:MARCH 6, 2015 (Filed With SEC on March 12, 2015)
